chrisvoncsefalvay/vaers-outcomes huggingface dataset:
EMPLOYEE SAT FOR 15 MINS AFTER INJECTION AND STATED HE FELT FINE. AT APPROXIMATELY 11:40 AM EMPLOYEE STATED HE FELT NAUSEOUS AND DIZZY AND ATTEMPTED TO PUT BOTTLES IN THE FREEZER AND RAN INTO THE WALL. NAUSEA SUBSIDED IN 2 MINUTES. DIZZINESS CONTINUED UNTIL TIME OF NOTE (1:11 PM) DONOR STATED HE HAD NOT EATEN TODAY. DONOR BLOOD PRESSURE 131/71 PULSE 72
Vaccination site - No Rx. Itching right leg (6-8cm reddened). 2 days later progressed to clear liquid vesicles. Day 4 increased in size, day 6 color changed to clear yellow blisters broke, painless. Edema- ankle, knee, upper calf. Day 4 cultures negative.
Facial flushing and light headed immediately after vaccine. Provided Juice and granola bar at 17:50.  Improved after a few minutes.
shingles and other zoster-related conditions; shingles and other zoster-related conditions; This initial spontaneous report was received on from a lawyer regarding a case in litigation and refers to a currently 75-years-old patient of unknown gender. The patient's concurrent conditions, medical history and concomitant medication were not provided.   On or about 01-JUN-2016, the patient was vaccinated with a dose zoster vaccine live (ZOSTAVAX) (dosage regimen was not reported) for the long-term prevention of shingles (herpes zoster) and zoster-related conditions.  On an unspecified date, subsequent to the patient vaccination, the patient was treated by a physician for the following injuries resulting from the zoster vaccine live (ZOSTAVAX) vaccination: herpes zoster-related injuries (ill-defined disorder). At the reporting time, the outcome of the event was unknown.   The reporter considered the events of herpes zoster-related injuries (ill-defined disorder) to be related to zoster vaccine live (ZOSTAVAX).
Pt called 9/17/20 to report after Hep A on 8/27. Pt began with flu-like symtoms on 8/28. (fatigue, low grade fever 100, cough, chest pressure, headache, some hives on chest.) Fevers range from 100 - 102.5 9/8/20 went to see PCP & had Blookwork & Covid test which was neg. pt presently still has symptoms.
Patient received Moderna Booster dose of 0.25ml IM on 3/11/2022. Called clinic on 3/15/22. Reports had weakness and "felt out of her head" beginning on 3/11/22. Reports on 3/12/22 had difficulty walking. Continues to have soreness and redness to injection site. Reports symptoms have all resolved except for the arm soreness. Did not seek medical treatment.
Arm swollen and red 2 days after vaccines. Cellulitis, ice to affected area x 10-15 min. TID. OTC Motrin PRN Q 6.
Last Fall I had a first shingles attack so in December I started the Shingrex two shot series, completed near the end of March.  I should note that although I am 80 years old, I had not had the flu or even a cold for years.  After the second shot I got the usual sore arm, worse the next day and that evening endless attacks of diarrhea, trouble breathing, coughing, a sleepless night.  I slept most of the next day, had little energy or appetite the rest of the week, and then came down with a Staphylococcus aureus bladder infection, cause unknown.
30 cm X 10 cm length width erythema, edema, tenderness, dryness to right arm
I felt fine the entire day I got the shot, but after falling asleep for the night I woke up feeling like I had the worst hangover of my life. Throbbing back of the head headache, nausea, vomiting, high fever with cold sweats, body aches, insomnia. It felt as though I drank an entire bottle of red wine to myself after not eating all day and went to bed without drinking any water, but worse. 12/10 would not recommend
This spontaneous prospective pregnancy report as received from Registered Nurse refers to a 23 year old female patient with HIV and with none drug reactions or allergies. The patient's history of previous pregnancies and live birth is unknown. The registered nurse reported that the patient was vaccinated on 15-FEB-2013 with GARDASIL injection, (lot# 1570Z and exp date 06-APR-2013) first dose, (dose and anatomical site of injection were not specified). Concomitant therapies included COMPLERA. The registered nurse reported that the patient about 20 weeks pregnant (second trimester) was administered the first dose of GARDASIL on 15-FEB-2013. The last menstrual period (LMP) was estimated on 28-SEP-2012 and Estimated Date of Delivery (EDD) on 05-JUL-2013. At the time of the report no adverse events were reported. There was no treatment given by the reporter. Laboratory tests were not performed. At the time of the report the pregnancy outcome was pending. Follow-up information received. The lot number 1570Z has been verified as valid with lot number 668260/1570Z for GARDASIL. Additional information is not expected.
Patient came into the pharmacy and reported nerve pain around back of his head after receiving the Shingrix vaccine.  He was examined by his neurologist and CT scan was performed.  According to patient, he stated that CT scan is clear. His doctor gave him Valtrex, Gabapentin, and Ibuprofen to treat his nerve pain.
Severe tinnitus - not going away 14+ days sore throat, chills, nausea, earache, muscle tremors, swollen joint, vertigo, visual disturbances - insomnia, heart palpitation.
After receiving her second dose of COVID (Moderna), the pt went to sit in the chairs for the post-immunization area but she was there with her grandparents who also received their 2nd doses before her.  They had walked over to get an item from the shelf and she went over to let them know she was done, at that time the grandparents said she was about to faint so they walked her over to the consultation area, supporting her under her arms then at that point she did faint. I was on my way over to the patient and helped the grandparents help her slide to the floor.  We laid her gently down on the floor where she immediately awoke and sat up, I recommended that she stay still, she did not want to lie back down where I was attempting to elevate her feet.  We called management and 911 when her grandparents took her over to the consultation window. While we waited for EMS to arrive, she was pale and sweaty, we took her blood pressure and it was 93/51, when EMS arrived she still had low blood pressure and complained of headache.  She said she had not eaten very much that day and had worked 9 days in a row.  When I was reviewing the screening form with the patient she denied having any adverse reactions to any immunizations in the past.  EMS recommended taking her to the hospital to monitor her low blood pressure and she agreed. Her grandmother stopped by the pharmacy later and said her blood pressure was returning to normal.
Severe vertigo hours 8-36 hours post injection. Telehealth RX for Zoltan.  Chills, shaking and fever 102.3 degrees 30-40 hours post injection. Severe diarreha (explosive for 12 hours) day 2-3.
Since 17 December he has complained of recurrent episodes of generalized itching and rashes described as raised, red, itchy whelts which can occur anywhere on his body, especially at sites of pressure or where his skin is scraped or scratched. Lesions last less than 24 hours, spares his palms and soles, and resolve without post-inflammatory changes. He reports intermittent episodes of mild, transient throat swelling and chest tightness which do not impact his ability to breath or swallow but otherwise denies pulmonary, GI, neurologic, and cardiovascular symptoms with these episodes. Episodes not associated with heat, exercise, sweating, cold, foods, medications, NSAIDs, IV contrast, latex exposure, infections, or insect bites/stings. He received his Moderna COVID-19 vaccine booster dose on 7 December, 10 days prior to onset of symptoms. He has used oral antihistamines with some benefit. He denies constitutional symptoms. UCT score today is 3 (0, 0, 0, 1, 0, 0, 1, 1). No history of adverse reactions to prior vaccines.
Starting having heart palpitations within  2 weeks of second dose of Moderna vaccine.   Am having what I would call either a skipped beat or a hesitation in a beat. In five minutes I can have as many as 20 skipped beats. This happened in October of 2021 and finally called my heart doctor and I did a heart monitor for 3 days. Doctor prescribed Metoprolol for it
This spontaneous report as received from a other health professional refers to a patient of unknown age. The patient was vaccinated with VARIVAX (merck). No other co-suspects were reported. No concomitant medications were reported. A medical assistant called and stated a person from the state told their office not to use VARIVAX since there were no temperature logs for AUG-2012 and SEP-2012. Medical assistant is not sure whether the temperature was out of range since there is no temperature logs. The healthcare worker reported that the patient was administered VARIVAX, then later finding out that the stability of that product was not longer any good. No adverse events were reported. Additional information has been requested.
BRIEF OVERVIEW: Admission Date: 8/21/2023 Discharge Date: Aug 22, 2023 Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypokalemia [E87.6] Moderate persistent asthma with exacerbation [J45.41] Acute COVID-19 [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE: 52-year-old female with past medical history of moderate persistent asthma, hypertension, pituitary micro adenoma status post resection, presented to the emergency department with a chief complaint of shortness of breath with productive cough.  Patient reported symptoms of fevers and chills for approximately 4 days prior to coming in.  On arrival to the emergency department, she was assessed to be likely an asthma exacerbation.  patient tested positive for COVID-19 and was noted with significant hypokalemia.  Patient was admitted for further workup of likely asthma exacerbation. Overnight patient had good response to steroids and did not require any supplemental oxygen.  Patient reports significant improvement in symptoms.  Electrolytes were replaced with suspected likely secondary to hydrochlorothiazide and reported nausea vomiting.   On discharge, hydrochlorothiazide was discontinued and hydralazine 10 mg 3 times a day was initiated.  Patient was advised to have close follow-up with PCP for further ambulatory blood pressure monitoring   In regards to her respiratory status, patient will be discharged on steroid taper with follow-up with PCP for further asthma management.  All questions and concerns addressed.  Patient discharged in stable condition.
I developed decreased hearing and tinnitus in my left ear 19 days after my second Pfizer/BioNTech COVID-19 vaccine (first dose was on 12/18/20) and was diagnosed with sudden sensorineural hearing loss. My symptoms improved (but did not completely resolve) after treatment with prednisone. I continue to have decreased hearing and tinnitus in my left  ear.
Swelling in my muscle, Top mid right chest. Chest pain, hurt to breath, pain into back.
12-22-2020 Evening started noticing soreness, redness & swelling at injection site. 12-23-2020 0230 am started "feeling Bad", felt feverish, chills, muscle pains, nausea, fatigue and dizziness along with swelling, redness, soreness at injection site. He states it resolved 12/24/2020. injection site soreness, redness & swelling resolved 12-26-2020
The 17 year-old patient fainted and lost the consciousness for approximately 3 minutes, 10 minutes after he received his first Pfizer vaccine. He was laid down on the ground, was given water and started to gain his consciousness slowly. He was palpitated, sweating, dehydrated, dizzy and nauseous. Blood pressure was checked 126/78, glucose 118. The reaction could be related to his diet as he has been fasting. He got better gradually when the medical team came. He was advise to keep hydrated and to eat. Patient was taken to the hospital for further check-up
her fever is being going up since 5 days; body aches/Hurting most of the days; tired; Arthritis; This is a spontaneous report from a contactable consumer. A 76-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number reported as looked like VAC DOD, cannot read whether that is OOD or DOD and then it was 7051 and cannot read the writing), via an unspecified route of administration on 21Dec2020 at single dose for preventive measure for Covid. Medical history included low thyroid, cholesterol, breast cancer surgery, high blood pressure, AFib (atrial fibrillation) incident. Concomitant medication included metoprolol for high blood pressure, tamoxifen after breast cancer surgery, fenofibrate for cholesterol, levothyroxine for low thyroid and unspecified medication for AFib incident. The patient got the first Covid vaccination at the hospital where she volunteer. Every day the patient was having more and more, a higher temperature. This morning in Dec2020, she got up at 102.2 and that was the highest it had been. It was 101 something yesterday (event onset reported as probably ever since the 22Dec20020 but each day the fever got worst). The patient also had the body aches but she had arthritis so it was really hard to tell if it just been a (incomplete sentence), what she was already hurting most of the days so it was hard to tell if the vaccine had to do anything but really tired. The outcome of events was unknown.  Information on the lot/batch number has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID arm). At the time of the report, VACCINATION SITE REACTION (COVID arm) outcome was unknown. mRNA-1273 (Spikevax) (Unknown) dosing remained unchanged. No concomitant medication was provided No treatment information reported. It was reported that the patient was ready to take the 2nd booster. This case was linked to MOD-2022-537748, MOD-2022-537749 (Patient Link).
COMPLETE RIGHT SIDE OF FACE HAD NO MUSCLE CONTROL ON SATURDAY. WENT TO DOCTOR ON THE FOLLOWING MONDAY AT 7AM AND WAS DIAGNOSED WITH BELL PALSY
Fever of 100.5,  4 hrs after vaccines given.  Then seizure at 10pm , 11 hrs after vaccines were given. Taken to the hospital.
Tested positive after receiving the vaccine; A spontaneous report was received from a reporter, concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and tested positive after receiving the vaccine.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On an unknown date, the patient received their first of two planned doses of mRNA-1273 intramuscularly (lot number unknown) for prophylaxis of COVID-19 infection.    On an unknown date, after administration, the patient tested positive and subsequently received mAb therapy. No additional information was provided. No treatment information was provided.   Action taken with mRNA-1273 vaccine was unknown.  The outcome of event, and tested positive after receiving the vaccine, was unknown.; Reporter's Comments: This case concerns a male of unknown age who experienced NS events of unexpected SARS-CoV-2 test positive and received mAb therapy for COVID-19.  Event onset occurred with unknown latency after the first dose of mRNA-1273. Event outcome unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
A female patient (age not specified) opened a small box of MENACTRA (lot number U2926AA) and as a result sustained a small cut on her left pink finger (date not provided). Two vials were broken into pieces. Initially the patient was reported as receiving one stitch, however additional information was received that stated the patient did not require stitched or antibiotics, just a bandage. the recovery status was not reported. No additional information was provided. List of Documents held by Sender: none.
had an anaphylactic reaction to Prevnar13; This is a spontaneous report from Pfizer sponsored program. A contactable consumer (patient) reported that a patient of unspecified age and gender received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at single dose for immunization. The relevant medical history and concomitant medications were not reported. The patient had an anaphylactic reaction to Prevnar 13 on an unspecified date. The patient was skeptical about getting the Covid vaccine. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
The vaccinee received an injection of Hep-B vaccine several days prior to 12/20/00 (exact date not provided) and sought medical attention on 12/20/00. She was treated with methylprednisolone (Medrol Dosepak). Outcome of the event was unknown as of 12/20/00. Additional information has been requested.
kidney failure; Heart failure; respiratory failure; High fever; 6.7 hemoglobin blood poisoning due to kidney function failure; 6.7 hemoglobin blood poisoning; Since the vaccination, the patient had been tested for COVID-19/ Test Nasal swab, Result Positive; Since the vaccination, the patient had been tested for COVID-19/ Test Nasal swab, Result Positive; This is a spontaneous report from a contactable consumer (patient). This 70-year-old-male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the arm right on 15Jun2021 at 19:00 as DOSE 1, SINGLE for COVID-19 immunization. There was no medical history or concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. On 24Jun2021, the patient experienced high fever, heart failure, kidney failure, respiratory failure, blood transfusion 6.7 hemoglobin blood poisoning due to kidney function failure 1 month in hospital. The duration of hospitalization was 20 days, no hospitalization prolonged. Events resulted in Emergency room/department or urgent care, hospitalization, life threatening illness (immediate risk of death from the event), disability or permanent damage. Therapeutic measures were taken as a result of 6.7 hemoglobin blood poisoning due to kidney function failure. Unknown if treatment received for high fever, heart failure, kidney failure, respiratory failure. Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, the patient had been tested for COVID-19. Lab data included nasal swab was positive in 2021, hemoglobin was 6.7 on 24Jun2021. Outcome of events "Since the vaccination, the patient had been tested for COVID-19/ Test Nasal swab, Result Positive" was unknown, while of the other events was not recovered.  The lot number for the vaccine bnt162b2 was not provided and will be requested during follow up.
Vaccine was given to a 15 year old; A spontaneous report was received from a pharmacist, concerning a 15-year-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and had event vaccine was given to a 15-year-old.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 20-Jan-2021, prior to the onset of event, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   On 20-Jan-2021, there might have been a mix up and the 15-year-old patient received the Moderna COVID-19 vaccine instead of the Pfizer vaccine. Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not reported.   The event, vaccine was given to a 15-year-old was considered resolved on 20-Jan-2021.; Reporter's Comments: This case concerns a 15-year-old female patient who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Product administered to patient of inappropriate age.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 10-AUG-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 ten 0.5ml single-dose vial (SDV) (lot # K019561, expiration date 20-APR-2016). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time (hour), the highest recorded temperature (Fahrenheit degree/ Celsius) and the type of excursion (R/F) for each time were 24, 47 and R; 112, 49 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
Aches all over, teeth-chattering chills, coughing, headache. All symptoms resolved by the morning of 9/26/11.
13MAY flu like sx- elevated temp (not documented) chest congestion, fatigue, chills, sweats; inject site reddened; sx abated 20MAY but feels weak & coughing still;
Information has been received from a pharmacist concerning his 72 year old wife, with high cholesterol, and an allergy to codeine, who approximately six months ago (approx. July 2007), was vaccinated with ZOSTAVAX.  Concomitant therapy included CRESTOR.  On 23-Dec-2007, the patient developed a shingles rash that presented on her jaw, face, ear, and scalp.  On 26-Dec-2007, she presented to the hospital with a chief complaint of pain and was hospitalized.  Treatment included unspecified intravenous pain medications, and intravenous acyclovir.  She was discharged after two nights in the hospital.  The reporter indicated that the rash had cleared (date unspecified, but the patient was still experiencing significant pain.  A product quality complaint was not reported.  Additional information has been requested.
This patient had pain and numbness in her right arm for 2 days after her 2nd Hepatitis B injection was administered. The patient has full movement and strength in her right arm. The patient also reports episodes of pain and tremoring in her right leg lasting only a few minutes on 12/5/00 and 12/6/00. The patient complained of fever, decreased appetite, nasal congestion, sore throat, headache that was relieved with Motrin, body aches, fatigue, and dizziness. Treatment: obtained CBC, LFT's, Sedrate. the patient is to rest, push fluids, and take Motrin. Follow up 12/08/00.
This case was reported by a pharmacist and described the occurrence of hepatitis A antibody negative in a male subject of unspecified age who was vaccinated with TWINRIX (GlaxoSmithKline). On 18 November 2011, 22 December 2011 and 29 May 2012 the subject received 1st dose, 2nd dose and 3rd dose of TWINRIX (unknown). On 24 July 2012, 56 days after vaccination with 3rd dose of TWINRIX, 7 months after vaccination with 2nd dose of TWINRIX, 8 months after vaccination with 1st dose of TWINRIX, the subject experienced hepatitis A antibody negative. The subject had a titer performed on 24 July 2012 Hepatitis A was non reactive and Hepatitis B was reactive. The healthcare professional reported several subjects did not respond to Hepatitis A vaccine; seven with HAVRIX and three with TWINRIX. For the other subjects please see cases A0994236A, A0994238A - A0994245A.
This case was reported by a physician and described the occurrence of injection site pain in adult female subjects (unknown number of subjects) who were vaccinated with BOOSTRIX (GlaxoSmithKline). Concurrent medical conditions included being thin, with weight ranging between 90 - 100 pounds. On unspecified dates the subjects received doses of BOOSTRIX (details unknown). A few days after vaccination with BOOSTRIX, the subjects experienced "severe" injection site pain and pain all over body. At the time of reporting the events were resolved (unknown timeframe). The physician was making a general observation that she had been noticing over an unknown period of time occurring in an unknown number of subjects.
One hour after receiving his shot, the patient said he experienced some chest pain and dehydration, which lasted about 48 hours.